Author | Ben Comer

Articles

Brexit Report: What's Next for the Industry?

Pharmaceutical Executive

Article

As the UK exits the European Union, the pharmaceutical and life sciences industries should prepare for changes by identifying key business issues, mitigating risks and creating plans for multiple scenarios.

Taking Flight: Pharm Exec's Top 50 Pharma Companies 2015

Pharmaceutical Executive

Article

 Specialty drug sales, record-breaking M&A paired with tax synergies, and global expansion helped to bring a new face into this year’s Pharma 50 top 10, and substantially boosted the rankings of several others.    

SciClone Pharmaceuticals: Selling Specialty Drugs in China

Pharmaceutical Executive

Article

Successfully commercializing a proprietary drug in China can be a Kafkaesque affair.

FDA Abroad

Pharmaceutical Executive

Article

FDA officials willing to relocate to far-flung global cities should be congratulated for their herculean efforts to protect American patients. But funding cuts hamper the Agency's international presence.